Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported positive results from an interim analysis of phase 2 trials for its COVID-19 vaccine, saying that the vaccine demonstrated high seroconversion rates and geometric mean titer (GMT) figures.
A seroconversion rate is the percentage of participants in a trial displaying virus-specific immune memory after being given a vaccine, while the GMT measures the level of neutralizing antibody response, Medigen said.
The experimental vaccine has a seroconversion rate of 99.8 percent and its GMT was 662 among the participants aged 20 to 89, while the gauges rose to 99.9 percent and 733 respectively in participants aged 20 to 64, the company said.
Photo: Screen grab from the Internet
No participants have shown severe adverse reactions, it said.
Only 0.7 percent of participants who were given experimental vaccines had a fever, compared with 0.4 percent in those who received a placebo, while among those who received the vaccine 27.6 percent had muscle soreness and 36 percent felt tired, compared with 16.6 percent and 29.7 percent respectively for those who were given a placebo, it said.
“It would be the regulator that decides if our experimental vaccine has good efficacy, but I personally found the results — the seroconversion rates and the GMT figures — optimistic,” Medigen chief executive officer Charles Chen (陳燦堅) said.
“And it is very safe,” Chen added.
The company will apply to the Food and Drug Administration for emergency use authorization as soon as possible, he said.
However, asked which COVID-19 vaccine developed outside Taiwan that has been granted emergency use authorization Medigen’s experimental vaccine might be compared to, the company said it has not reached a conclusion.
“An estimate needs to be done scientifically. We can conduct an immune-bridging study to compare the antibody levels in people who are given different COVID-19 vaccines, and the WHO is also trying to establish common standards for COVID-19 vaccines,” Medigen head of development Lien Chia-en (連加恩) said.
For example, Medigen’s clinical trial result of a GMT of 662 could be converted into international units (IU) and foreign vaccine developers could do likewise to enable international comparison, Lien said.
“However, this would take some time and other companies have not disclosed their data in IU yet,” he said.
Amid discussions over whether locally developed COVID-19 vaccines would be better than foreign vaccines, Chen and Medigen spokesman Leo Lee (李思賢) said that they are confident in their product and they and their families would get Medigen’s vaccine.
Medigen is to conduct phase 3 trials for its vaccine to earn approval from foreign regulators and it aims to conduct the tests in Europe, Chen said, adding that the UK recently allowed a French company to conduct phase 3 human testing there.
It costs about US$10,000 per participant in phase 3 trials, so the costs would be enormous if Medigen recruited 30,000 participants, Chen said.
A Taiwanese YouTuber suspected of creating and selling deepfake porn videos featuring more than 100 politicians and influencers was on Monday released on bail after being arrested the previous day. Chu Yu-chen (朱玉宸), 26, who uses the name Xiaoyu (小玉) on YouTube, was arrested on Sunday in New Taipei City, along with two suspected accomplices, a 24-year-old YouTuber surnamed Yeh (耶), known as Shaiw Shaiw (笑笑), and a 22-year-old man Chuang (莊). The three suspects were on Monday escorted to the New Taipei District Prosecutors’ Office for further questioning on suspicion of distributing obscene videos and publicly insulting others, in contravention of
ANTI-COERCION: EU Commissioner for Competition Margrethe Vestager said the EU wishes to bolster relations with Taiwan within the framework of its ‘one China’ policy The EU is to further its engagement with Taiwan to defend democracy, freedom and an open market, while bolstering cooperation in semiconductor supply chains, EU Commissioner for Competition Margrethe Vestager said on Tuesday. In her remarks at a European Parliament plenary session focused on Taiwan-EU relations, Vestager referred to China’s increasing military presence in the Taiwan Strait, including flying missions off the southwest coast of Taiwan. “This display of force may have a direct impact on European security and prosperity,” she said, adding that the EU encourages all parties to avoid any unilateral actions that might increase tensions across the Strait. “We Europeans
Hon Hai Precision Industry Co (鴻海精密) yesterday debuted three electric vehicle (EV) prototypes to great fanfare at its Tech Day event at the Taipei Nangang Exhibition Center. The prototypes of sports utility vehicle Model C, luxury sedan Model E and electric bus Model T were developed by Foxtron Vehicles Technologies Co (鴻華先進), a joint venture between Hon Hai and Yulon Motor Co (裕隆汽車). The Model C and Model E are to be initially sold under the Yulon-affiliated Luxgen Motor Co (納智捷汽車) and China Motor Corp (中華汽車) brands when they hit the market, Hon Hai chairman Young Liu (劉揚偉) said. The company expects
MILITARY RESOLVE: Washington does not want a cold war with Beijing, it just wants ‘China to understand that we’re not going to step back,’ Biden told a CNN town hall The US would come to Taiwan’s defense and has a commitment to defend the nation China claims as its own, US President Joe Biden said on Thursday, although the White House later said there was no change in policy toward Taiwan. “Yes, we have a commitment to do that,” Biden said at a CNN town hall meeting when asked if the US would come to the defense of Taiwan, which has been facing mounting military and political pressure from Beijing to accept Chinese sovereignty. While Washington is required by law to provide Taiwan with the means to defend itself, it has long